This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches

Read more

  • Cooperation studies on inherited susceptibility to colorectal cancer
  • TRANSCOLONCAN Group
  • Graphic
COST is supported by the EU Framework Programme Horizon 2020